|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4155 | |
| A61K 31/69 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2663189 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12733916.6 |
| Europos patento paraiškos padavimo data | 2012-01-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-11-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-07-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/020863 |
| Data | 2012-01-11 |
| (87) | Numeris | WO 2012/097021 |
| Data | 2012-07-19 |
| (30) | Numeris | Data | Šalis |
| 201161431508 P | 2011-01-11 | US |
| (72) |
KUMAR, Rakesh, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMBINATION OF BORTEZOMIB WITH AFURESERTIB AND USE THEREOF IN THE TREATMENT OF CANCER |
| COMBINATION OF BORTEZOMIB WITH AFURESERTIB AND USE THEREOF IN THE TREATMENT OF CANCER |